Speaker Detail

Vicki Seyfert-Margolis is senior advisor for science innovation and policy in the FDA Commissioner's Office, focusing on innovation, regulatory science, personalized medicine, scientific computing and health informatics. Previously, she was chief scientific officer at the Immune Tolerance Network, a research consortium seeking treatments for immune system diseases. At ITN, she oversaw the development of 20 laboratory facilities and the design and execution of biomarker discovery studies for more than 25 Phase II clinical trials. In her biomarker efforts, she established construction of a primer library of 1,000 genes that may be involved in immunologic tolerance and co-discovered genes that may mark kidney transplant tolerance. Seyfert-Margolis was also an adjunct associate professor at the University of California, San Francisco. Prior to academia, she directed the Office of Innovative Scientific Research Technologies at the National Institute of Allergy and Infectious Diseases. Seyfert-Margolis earned a Ph.D. in immunology at the University of Pennsylvania's school of medicine.